1.
Int J Dermatol
; 58(3): e64-e66, 2019 Mar.
Article
En
| MEDLINE
| ID: mdl-30478828
Acantholysis/diagnosis , Immunoglobulin A/immunology , Pyoderma/diagnosis , Stomatitis/diagnosis , Acantholysis/pathology , Biopsy , Diagnosis, Differential , Humans , Male , Pemphigus/diagnosis , Pemphigus/pathology , Penis/immunology , Penis/pathology , Pyoderma/pathology , Skin/immunology , Skin/pathology , Stomatitis/pathology
2.
Eur J Dermatol
; 27(3): 337-338, 2017 Jun 01.
Article
En
| MEDLINE
| ID: mdl-28677584
Antimetabolites, Antineoplastic/adverse effects , Drug Eruptions/etiology , Fluorouracil/adverse effects , Lupus Erythematosus, Cutaneous/chemically induced , Adenocarcinoma/therapy , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Exanthema , Humans , Male , Rectal Neoplasms/therapy
3.
Eur J Dermatol
; 27(6): 679-680, 2017 Dec 01.
Article
En
| MEDLINE
| ID: mdl-29311047
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Hyperpigmentation/chemically induced , Adenocarcinoma/drug therapy , Adult , Antibodies, Monoclonal, Murine-Derived/adverse effects , Bevacizumab/adverse effects , Colonic Neoplasms/drug therapy , Cyclophosphamide/adverse effects , Doxorubicin/adverse effects , Fluorouracil/adverse effects , Humans , Hyperpigmentation/pathology , Leucovorin/adverse effects , Lymphoma, Large B-Cell, Diffuse/drug therapy , Male , Middle Aged , Organoplatinum Compounds/adverse effects , Prednisone/adverse effects , Rituximab , Vincristine/adverse effects